Literature DB >> 8787147

Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy.

T Kanda1, H Tsukagoshi, M Oda, K Miyamoto, H Tanabe.   

Abstract

Quantitative changes in unmyelinated nerve fibers (UMNFs) of sural nerves in patients of amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD) and multiple system atrophy (MSA) were evaluated using autopsy materials whose pathological diagnosis had been confirmed by careful postmortem examinations. Ordinary ALS cases demonstrated no involvement in cutaneous UMNFs; however, the patients with long survival due to the application of ventilatory support showed bimodality in UMNF diameter histograms, and a patient with involvement of systems other than motor pathways showed an abnormal value in two indices: a low percentage of subunits containing axon(s) and a high mean number of Schwann cell profiles per axon. A significant reduction of the mean value of UMNF density (21%) was found in PD patients. Because the density of myelinated nerve fibers did not show any significant decrease as compared with age-matched controls, the change of nerve fibers in peripheral nervous system was considered to be confined to UMNFs in PD. Elderly PD cases showed enhanced changes in the ageing process, as expressed by the two indices described above. In MSA, the mean value of UMNF density was significantly decreased (23%), and this decrease almost paralleled that of myelinated nerve fiber density. Abnormal values for the two indices described above were found and two out of four cases demonstrated bimodality in the diameter histogram of UMNFs. Unlike MSA, ALS and PD have not been included in the disorders with cutaneous UMNF involvement. Our results supply the first evidence of morphological changes in cutaneous UMNFs in PD cases. In ordinary ALS cases, the emergence of such morphological changes is suggested in cases with long survival.

Entities:  

Mesh:

Year:  1996        PMID: 8787147     DOI: 10.1007/s004010050406

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  Behaviour of peripheral nerve structures in chronic neuropathies, with special reference to the Schwann cell.

Authors:  J Ochoa; J D Vial
Journal:  J Anat       Date:  1967-11       Impact factor: 2.610

2.  Autonomic deficits in Parkinson's syndrome.

Authors:  O Appenzeller; J E Goss
Journal:  Arch Neurol       Date:  1971-01

3.  Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.

Authors:  J G Graham; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

4.  Peripheral Nerve unmyelinated axons following lumbar sympathectomy.

Authors:  D Chad; G M Shoukimas; W G Bradley; E P Bosch; B T Shahani; R R Young
Journal:  Ann Neurol       Date:  1981-11       Impact factor: 10.422

5.  Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state.

Authors:  H Hayashi; S Kato
Journal:  J Neurol Sci       Date:  1989-10       Impact factor: 3.181

6.  Peripheral neuropathy in multiple system atrophy with autonomic failure.

Authors:  G Galassi; R Nemni; A Baraldi; M Gibertoni; A Colombo
Journal:  Neurology       Date:  1982-10       Impact factor: 9.910

7.  Unmyelinated axon subpopulations in the rat peripheral nervous system.

Authors:  D Chad; C Rasool; W G Bradley; P Good; S Reichlin
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

8.  Morphometric study of the sensory nerve in classical (or Charcot disease) and juvenile amyotrophic lateral sclerosis.

Authors:  M Ben Hamida; F Letaief; F Hentati; C Ben Hamida
Journal:  J Neurol Sci       Date:  1987-05       Impact factor: 3.181

9.  Dysautonomia in Parkinsonism: a clinicopathological study.

Authors:  A H Rajput; B Rozdilsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

10.  Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus).

Authors:  P A Fischer
Journal:  Adv Neurol       Date:  1987
View more
  10 in total

Review 1.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 2.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

3.  Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy.

Authors:  Rie Haga; Kazuhiro Sugimoto; Haruo Nishijima; Yasuo Miki; Chieko Suzuki; Koichi Wakabayashi; Masayuki Baba; Soroku Yagihashi; Masahiko Tomiyama
Journal:  Parkinsons Dis       Date:  2015-04-06

4.  Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy.

Authors:  Keiko Nakamura; Fumiaki Mori; Tomoya Kon; Kunikazu Tanji; Yasuo Miki; Masahiko Tomiyama; Hidekachi Kurotaki; Yasuko Toyoshima; Akiyoshi Kakita; Hitoshi Takahashi; Masahito Yamada; Koichi Wakabayashi
Journal:  Acta Neuropathol Commun       Date:  2015-05-21       Impact factor: 7.801

5.  Conditioned pain modulation in drug-naïve patients with de novo Parkinson's disease.

Authors:  Wiebke Grashorn; Odette Fründt; Carsten Buhmann; Nathalie Wrobel; Katharina Schmidt; Ulrike Bingel
Journal:  Neurol Res Pract       Date:  2019-08-26

Review 6.  Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core.

Authors:  Elena Vacchi; Alain Kaelin-Lang; Giorgia Melli
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

7.  Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype.

Authors:  Daniela Kuzdas-Wood; Regina Irschick; Markus Theurl; Philipp Malsch; Norbert Mair; Christine Mantinger; Julia Wanschitz; Lars Klimaschewski; Werner Poewe; Nadia Stefanova; Gregor K Wenning
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

8.  Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease.

Authors:  Hui Zhang; Jing Wu; Fei-Fei Shen; Yong-Sheng Yuan; Xiao Li; Pan Ji; Lin Zhu; Li Sun; Jian Ding; Qi Niu; Ke-Zhong Zhang
Journal:  CNS Neurosci Ther       Date:  2019-12-11       Impact factor: 5.243

Review 9.  Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences.

Authors:  Dariusz Koziorowski; Monika Figura; Łukasz M Milanowski; Stanisław Szlufik; Piotr Alster; Natalia Madetko; Andrzej Friedman
Journal:  Cells       Date:  2021-03-16       Impact factor: 6.600

10.  Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.

Authors:  Rachel Rohmann; Eva Kühn; Raphael Scherbaum; Lovis Hilker; Saskia Kools; Leonard Scholz; Katharina Müller; Sophie Huckemann; Christiane Schneider-Gold; Ralf Gold; Kalliopi Pitarokoili; Lars Tönges; Eun Hae Kwon
Journal:  Brain Sci       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.